Get ready to mark your calendars because the much anticipated third quarter financial results of Travere Therapeutics (NASDAQ: TVTX) are set to be unveiled on Thursday 31st October 2024. Investors and market watchers will have the chance to dive into the company's financial performance as the announcement is scheduled before market open.
Wall Street financial experts forecast that the firm is set to announce an expected $0.66 loss per share for the quarter. Moreover, the company is anticipated to disclose a total revenue of $59.7 million for this particular period.
Examining the corresponding quarter from the previous year, the company's earnings report unveiled a income of $2.27 per share. This number was attributed to the company's total revenue, which settled at an impressive $37.1 million during the same period.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $223.32 million. Additionally, they are expecting the company to achieve a per share loss of $3.71 for the fiscal year 2024.
In addition, The firm will review the third quarter financial results on 31st October 2024 at 08:30 AM eastern time, in a conference call with public.
Throughout Tuesday's trading, Travere Therapeutics (TVTX) shares fluctuated between $17.48 and $18.39, with a trading volume of 838.50 thousand shares. The stock ended the regular trading session at $18.37, marking a gain of 2.74 percent.
